Johann M E Jende1, Zoltan Kender2, Christoph Mooshage1, Jan B Groener2,3,4, Lucia Alvarez-Ramos2, Jennifer Kollmer1, Alexander Juerchott1, Artur Hahn1, Sabine Heiland1,5, Peter Nawroth2,4,6, Martin Bendszus1, Stefan Kopf2,4, Felix T Kurz1. 1. Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. 2. Department of Endocrinology, Diabetology and Clinical Chemistry, Heidelberg University Hospital, Heidelberg, Germany. 3. Medicover Neuroendocrinology, Munich, Germany. 4. German Center of Diabetes Research (DZD), Associated Partner in the DZD, München-Neuherberg, Germany. 5. Division of Experimental Radiology, Department of Neuroradiology, Heidelberg, Germany. 6. Joint Institute for Diabetes and Cancer at Helmholtz-Zentrum Munich and Heidelberg University, Heidelberg, Germany.
Abstract
BACKGROUND: Nerve damage in diabetic neuropathy (DN) is assumed to begin in the distal legs with a subsequent progression to hands and arms at later stages. In contrast, recent studies have found that lower limb nerve lesions in DN predominate at the proximal sciatic nerve and that, in the upper limb, nerve functions can be impaired at early stages of DN. MATERIALS AND METHODS: In this prospective, single-center cross-sectional study, participants underwent diffusion-weighted 3 Tesla magnetic resonance neurography in order to calculate the sciatic nerve's fractional anisotropy (FA), a surrogate parameter for structural nerve integrity. Results were correlated with clinical and electrophysiological assessments of the lower limb and an examination of hand function derived from the Purdue Pegboard Test. RESULTS: Overall, 71 patients with diabetes, 11 patients with prediabetes and 25 age-matched control subjects took part in this study. In patients with diabetes, the sciatic nerve's FA showed positive correlations with tibial and peroneal nerve conduction velocities (r = 0.62; p < 0.001 and r = 0.56; p < 0.001, respectively), and tibial and peroneal nerve compound motor action potentials (r = 0.62; p < 0.001 and r = 0.63; p < 0.001, respectively). Moreover, the sciatic nerve's FA was correlated with the Pegboard Test results in patients with diabetes (r = 0.52; p < 0.001), prediabetes (r = 0.76; p < 0.001) and in controls (r = 0.79; p = 0.007). CONCLUSION: This study is the first to show that the sciatic nerve's FA is a surrogate marker for functional and electrophysiological parameters of both upper and lower limbs in patients with diabetes and prediabetes, suggesting that nerve damage in these patients is not restricted to the level of the symptomatic limbs but rather affects the entire peripheral nervous system.
BACKGROUND: Nerve damage in diabetic neuropathy (DN) is assumed to begin in the distal legs with a subsequent progression to hands and arms at later stages. In contrast, recent studies have found that lower limb nerve lesions in DN predominate at the proximal sciatic nerve and that, in the upper limb, nerve functions can be impaired at early stages of DN. MATERIALS AND METHODS: In this prospective, single-center cross-sectional study, participants underwent diffusion-weighted 3 Tesla magnetic resonance neurography in order to calculate the sciatic nerve's fractional anisotropy (FA), a surrogate parameter for structural nerve integrity. Results were correlated with clinical and electrophysiological assessments of the lower limb and an examination of hand function derived from the Purdue Pegboard Test. RESULTS: Overall, 71 patients with diabetes, 11 patients with prediabetes and 25 age-matched control subjects took part in this study. In patients with diabetes, the sciatic nerve's FA showed positive correlations with tibial and peroneal nerve conduction velocities (r = 0.62; p < 0.001 and r = 0.56; p < 0.001, respectively), and tibial and peroneal nerve compound motor action potentials (r = 0.62; p < 0.001 and r = 0.63; p < 0.001, respectively). Moreover, the sciatic nerve's FA was correlated with the Pegboard Test results in patients with diabetes (r = 0.52; p < 0.001), prediabetes (r = 0.76; p < 0.001) and in controls (r = 0.79; p = 0.007). CONCLUSION: This study is the first to show that the sciatic nerve's FA is a surrogate marker for functional and electrophysiological parameters of both upper and lower limbs in patients with diabetes and prediabetes, suggesting that nerve damage in these patients is not restricted to the level of the symptomatic limbs but rather affects the entire peripheral nervous system.
Authors: P P Nawroth; M Bendszus; M Pham; J Jende; S Heiland; S Ries; C Schumann; M Schmelz; S Schuh-Hofer; R D Treede; R Kuner; D Oikonomou; J B Groener; S Kopf Journal: Neuroscience Date: 2017-09-20 Impact factor: 3.590
Authors: Johann M E Jende; Gesa H Hauck; Ricarda Diem; Markus Weiler; Sabine Heiland; Brigitte Wildemann; Mirjam Korporal-Kuhnke; Wolfgang Wick; John M Hayes; Johannes Pfaff; Mirko Pham; Martin Bendszus; Jennifer Kollmer Journal: Ann Neurol Date: 2017-10-26 Impact factor: 10.422
Authors: Stefan Kopf; Jan B Groener; Zoltan Kender; Thomas Fleming; Maik Brune; Christin Riedinger; Nadine Volk; Esther Herpel; Dominik Pesta; Julia Szendrödi; Mark O Wielpütz; Hans-Ulrich Kauczor; Hugo A Katus; Michael Kreuter; Peter P Nawroth Journal: Respiration Date: 2018-06-06 Impact factor: 3.580
Authors: Solomon Tesfaye; Nish Chaturvedi; Simon E M Eaton; John D Ward; Christos Manes; Constantin Ionescu-Tirgoviste; Daniel R Witte; John H Fuller Journal: N Engl J Med Date: 2005-01-27 Impact factor: 91.245
Authors: Jos Oudeman; Filip Eftimov; Gustav J Strijkers; Joppe J Schneiders; Stefan D Roosendaal; Maurits P Engbersen; Martijn Froeling; H Stephan Goedee; Pieter A van Doorn; Matthan W A Caan; Ivo N van Schaik; Mario Maas; Aart J Nederveen; Marianne de Visser; Camiel Verhamme Journal: Neurology Date: 2019-12-11 Impact factor: 9.910
Authors: Gonzalo Barrio-Arranz; Rodrigo de Luis-García; Antonio Tristán-Vega; Marcos Martín-Fernández; Santiago Aja-Fernández Journal: PLoS One Date: 2015-10-12 Impact factor: 3.240
Authors: Johann M E Jende; Zoltan Kender; Jakob Morgenstern; Pascal Renn; Christoph Mooshage; Alexander Juerchott; Stefan Kopf; Peter P Nawroth; Martin Bendszus; Felix T Kurz Journal: Front Neurosci Date: 2022-01-24 Impact factor: 4.677
Authors: Fabian Preisner; Rouven Behnisch; Véronique Schwehr; Tim Godel; Daniel Schwarz; Olivia Foesleitner; Philipp Bäumer; Sabine Heiland; Martin Bendszus; Moritz Kronlage Journal: Front Neurosci Date: 2022-02-16 Impact factor: 4.677
Authors: Anna Vágvölgyi; Ágnes Maróti; Mónika Szűcs; Csongor Póczik; Dóra Urbán-Pap; István Baczkó; Attila Nemes; Éva Csajbók; Krisztián Sepp; Péter Kempler; Andrea Orosz; Tamás Várkonyi; Csaba Lengyel Journal: Front Endocrinol (Lausanne) Date: 2021-08-27 Impact factor: 5.555
Authors: Thorsten Lichtenstein; Alina Sprenger; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Helmar C Lehmann; Tobias D Henning Journal: Front Neurosci Date: 2021-08-26 Impact factor: 4.677
Authors: Matthew C Evans; Charles Wade; David Hohenschurz-Schmidt; Pete Lally; Albert Ugwudike; Kamal Shah; Neal Bangerter; David J Sharp; Andrew S C Rice Journal: Front Neurosci Date: 2021-09-21 Impact factor: 4.677
Authors: Jakob Morgenstern; Jan B Groener; Johann M E Jende; Felix T Kurz; Alexander Strom; Jens Göpfert; Zoltan Kender; Maxime Le Marois; Maik Brune; Rohini Kuner; Stephan Herzig; Michael Roden; Dan Ziegler; Martin Bendszus; Julia Szendroedi; Peter Nawroth; Stefan Kopf; Thomas Fleming Journal: Diabetologia Date: 2021-09-03 Impact factor: 10.122
Authors: Johann M E Jende; Christoph Mooshage; Zoltan Kender; Stefan Kopf; Jan B Groener; Sabine Heiland; Alexander Juerchott; Peter Nawroth; Martin Bendszus; Felix T Kurz Journal: Front Neurosci Date: 2022-02-15 Impact factor: 4.677
Authors: Ratthaporn Boonsuth; Rebecca S Samson; Carmen Tur; Marco Battiston; Francesco Grussu; Torben Schneider; Masami Yoneyama; Ferran Prados; Antrea Ttofalla; Sara Collorone; Rosa Cortese; Olga Ciccarelli; Claudia A M Gandini Wheeler-Kingshott; Marios C Yiannakas Journal: Front Neurol Date: 2021-11-25 Impact factor: 4.003